Trials / Unknown
UnknownNCT03581578
VITROS Immunodiagnostic Products hs Troponin I
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,630 (estimated)
- Sponsor
- Ortho-Clinical Diagnostics, Inc. · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical study is to collect data to substantiate the use of the VITROS hs Troponin I test as an aid in the diagnosis of myocardial infarction (MI). The test is further indicated for risk stratification of mortality, myocardial infarction or coronary revascularization in patients with acute coronary syndrome.
Detailed description
A prospective clinical sample collection and cardiac troponin I testing will be conducted in individuals presenting to the Emergency Department (ED) with signs and/or symptoms suggestive of acute coronary syndrome (ACS) at geographically dispersed sites in the US. Individuals who meet the inclusion/exclusion criteria, including having signed an informed consent form will be included in the study. Clinical and laboratory data will be collected to demonstrate product performance compared to an adjudicated clinical diagnosis. Sample collection and testing of clinical samples with the VITROS hs Troponin I test will be performed under two separate protocols.
Conditions
Timeline
- Start date
- 2018-06-07
- Primary completion
- 2020-05-30
- Completion
- 2021-06-01
- First posted
- 2018-07-10
- Last updated
- 2020-09-16
Locations
24 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03581578. Inclusion in this directory is not an endorsement.